A university exclusive license can end in several ways — expiration of its stated term, mutual agreement, or, most contentiously, termination for a licensee’s failure to meet diligence milestones. CASRAI’s guide to diligence milestones and termination-for-failure-to-commercialize clauses covers that trigger mechanism in depth: how milestones are set, negotiated, and enforced, and the graduated remedies (cure periods, field-specific conversion, full termination) an institution typically works through before a license actually ends. This guide starts where that one stops. Once a university exclusive license terminates — for any reason, not only diligence failure — a separate set of clauses determines what actually happens to the patent rights, the sublicenses the licensee may have granted, the confidential information exchanged, and any improvements the licensee developed. Those post-termination disposition provisions are frequently under-negotiated relative to the termination trigger itself, which is a mistake: a termination clause with no clear reversion, survival, or sublicense-disposition language can leave an institution holding rights it cannot practically re-license, or a well-performing sublicensee stranded with no path to continue.
How a License Reaching Termination Differs From What Happens Next
Termination is an event; disposition is everything that follows it. A license agreement’s termination article typically does two distinct jobs that are easy to conflate: it defines the triggers and mechanics for ending the agreement (breach, failure to meet diligence obligations, bankruptcy, convenience termination by the licensee, and so on), and, separately, it defines the legal and practical consequences once termination actually occurs. The first job is what CASRAI’s diligence milestones guide addresses in depth for the commercialization-failure trigger specifically; the same disposition provisions discussed below generally apply regardless of which trigger caused the termination, whether that is failure to commercialize, an uncured material breach, licensee insolvency, or the licensee’s own convenience termination on notice. For the surrounding structure of a license agreement as a whole — grant of rights, royalties, sublicensing, indemnification — see CASRAI’s guide to license agreement structure.
Reversion of Patent Rights to the University
In the standard university licensing model, the institution retains title to the licensed patents throughout the relationship; the licensee holds a license to practice them, not ownership. “Reversion” in this context does not usually mean reassigning a patent back to the university, because the university never stopped owning it. What reverts is the licensee’s right to practice the patent, and, where the license was exclusive, the exclusivity itself: on termination, the licensee’s rights under the grant clause cease, the field and territory the licensee controlled become available for the institution to license to someone else, and any exclusivity commitment the institution made not to license competitively lapses. Well-drafted termination clauses make this an automatic effect of termination rather than something requiring further action — the license simply states that “upon termination, all rights granted to Licensee under this Agreement shall immediately revert to and be retained by the University” or equivalent language — because a reversion that depends on a further affirmative step by either party is a reversion that can get stuck in dispute exactly when the institution most needs a clean rights position to re-license the technology. Practical items institutions typically address alongside the reversion language: who bears ongoing patent prosecution and maintenance costs the licensee had previously been funding (commonly a defined transition period, after which the institution decides whether to continue prosecution at its own expense or allow the application/patent to lapse), and whether the licensee must execute any documents needed to clear title — for example, if the licensee’s name appears as an assignee or co-owner on a foreign filing made under a delegated-prosecution clause, or on a jointly filed improvement patent.
What Happens to Sublicenses When the Head License Terminates
Where the license permitted sublicensing, a terminated head license creates a real problem: what happens to sublicensees who may have invested in good faith and be actively developing or selling under rights that flow entirely from an agreement they were not a party to and cannot control? University licenses handle this in a few recurring ways, and which one applies is a heavily negotiated point:
- Automatic termination of sublicenses. The simplest drafting approach: sublicenses terminate automatically when the head license terminates, because a sublicense cannot convey rights the licensee no longer holds. This is clean for the institution but can be commercially harsh to a sublicensee that had nothing to do with the licensee’s default.
- Direct-license (step-in) rights for sublicensees in good standing. The more commercially common approach in mature university licensing practice: a sublicensee that is not itself in breach, and that is willing to assume obligations to the institution substantially equivalent to what it owed the (now-terminated) licensee, can request a direct license from the university on terms no more burdensome than its existing sublicense. This preserves continuity for a sublicensee that was performing even though the licensee above it was not, and it preserves value for the institution — an active sublicensee generating royalties is worth more than a lapsed relationship. Institutions typically condition this on the sublicensee being current on payment obligations and not itself a cause of the termination, and on the direct license flowing through the institution’s own standard audit, indemnification, and reporting terms even if the original sublicense did not include them.
- Assignment or “reverted licensee” treatment. A less common but recognized variant: rather than sublicenses terminating and being replaced with a fresh direct license, the sublicense agreement itself is deemed assigned to the institution, with the institution stepping into the licensee’s shoes as the sublicensor of record going forward, subject to whatever consents the underlying sublicense requires.
Which model a given license uses, and under what conditions, should be spelled out explicitly rather than left to inference from silence — silence tends to be read, after the fact and under dispute conditions, as “sublicenses terminate,” which is the outcome most likely to strand a performing sublicensee and most likely to generate a dispute the institution did not anticipate at drafting time.
Survival Clauses: What Contractually Outlives Termination
Termination ends the forward-looking license grant, but a well-drafted agreement specifies which obligations survive it regardless. A typical survival clause in a university license carries forward, at minimum:
- Accrued payment obligations. Royalties, milestone payments, minimum annual royalties, and patent-cost reimbursements that accrued before the termination date remain owed and payable on their original schedule; termination is not a defense to a payment obligation that had already accrued.
- Confidentiality. Obligations not to disclose or misuse the other party’s confidential information typically survive for a fixed term after termination (commonly several years, sometimes matched to the term used elsewhere in the agreement) rather than terminating with the license itself; true trade-secret-level information is sometimes carried on an indefinite or “for as long as it remains a trade secret” basis rather than a fixed term.
- Accrued indemnification and product liability exposure. A licensee’s indemnification obligations, and any requirement to maintain product liability insurance, typically survive for products the licensee sold or activities it undertook before termination — a claim arising from a product sold under the license two years before termination does not disappear because the license itself has since ended.
- Audit rights. The institution’s right to audit royalty reports for a defined look-back period commonly survives termination specifically so it can be exercised against the final accounting period. See CASRAI’s guide to royalty audit rights for how these clauses work in force.
- Limitation of liability, dispute resolution, and governing law. Structural clauses that need to remain enforceable to resolve any dispute arising from the now-ended relationship.
- A defined sell-off or wind-down period. Many licenses give a terminated licensee a short, fixed window (commonly a matter of months) to sell off existing finished-goods inventory manufactured before termination, subject to continuing to pay royalties on those sales, rather than requiring an instantaneous halt that would otherwise strand product the licensee had already lawfully manufactured.
Confidential Information and Technical Know-How
Beyond the confidentiality survival term itself, university licenses commonly require a terminated licensee to return or destroy the institution’s confidential information and materials (lab notebooks excerpts, unpublished data, biological materials, source code, and similar items shared under the agreement), often with a written certification of destruction where physical return is impractical. A genuinely contested area in practice is “residual knowledge” or “head-based” carve-outs — language permitting a licensee’s personnel to continue using general knowledge and skills retained in unaided memory, as opposed to the confidential information itself, after termination. Institutions vary in how much residual-knowledge language they will accept, since a residuals clause drafted too broadly can functionally undercut the confidentiality obligation it sits next to; where included, it is typically narrowed to exclude anything that would qualify as patentable subject matter, a trade secret, or specific technical data, leaving only genuinely general skills and know-how.
Improvements Developed by the Licensee
If the license included a grant-back or improvement clause — see CASRAI’s guide to grant-back and improvement clauses for how those are structured — termination raises a distinct question from the base patent reversion: what happens to improvements the licensee itself developed, whether jointly owned, exclusively licensed back to the institution, or retained solely by the licensee depending on how the grant-back clause was written. A grant-back obligation that already ran (an improvement the licensee disclosed and licensed back to the institution before termination) is generally unaffected by the later termination; the institution keeps whatever rights in that specific improvement it already received. Going forward, a terminated licensee typically has no further obligation to disclose or license back improvements it develops after the termination date, since the ongoing relationship that created the grant-back obligation has ended — which is one reason institutions negotiate grant-back rights to attach as improvements are made, rather than relying on the relationship remaining intact indefinitely.
“Use-It-or-Lose-It” Clauses: Where the Term Comes From and What It Actually Triggers
“Use-it-or-lose-it” is not a formal legal term of art; it is informal industry shorthand — used by technology transfer professionals and in trade commentary — for the diligence-and-termination-for-failure-to-commercialize structure CASRAI’s companion guide covers in detail: if a licensee does not actively develop and commercialize a licensed technology, the institution can reclaim the rights it granted. Two things worth being precise about when the phrase comes up: first, the trigger mechanics (what counts as a milestone, what cure rights apply, what evidentiary standard applies to “failure”) are covered by the diligence guide, not this one — this page picks up at the point a use-it-or-lose-it termination has actually been exercised, and covers the same reversion, sublicense-disposition, and survival mechanics described above. Second, “use it or lose it” is sometimes applied at less than the whole-license level: a field-of-use or territory-specific diligence failure can trigger conversion of an exclusive grant to non-exclusive in just that field or territory, or reversion of just that slice of the grant, rather than terminating the entire agreement — see CASRAI’s guide to field-of-use restrictions for how licenses are structured to make that kind of partial reversion possible in the first place.
Federally Funded Inventions: Bayh-Dole Considerations After Termination
Where the underlying invention was made with federal funding and the university elected to retain title under the Bayh-Dole Act (35 U.S.C. section 200 et seq.), termination of a commercial license does not end the institution’s own statutory obligations. The Act’s underlying policy is to see federally funded inventions reach practical application (35 U.S.C. section 200); an institution whose exclusive licensee has failed to commercialize and had its license terminated is, if anything, squarely back in the position the statute anticipates — needing to find another path to utilization, whether a new licensee, a different exclusive or non-exclusive structure, or startup formation. The federal government’s own march-in rights under 35 U.S.C. section 203, and its retained royalty-free license to practice the invention for government purposes, are unaffected by a commercial license terminating; they attach to the underlying subject invention itself, independent of whoever currently holds a commercial license to it. Institutions terminating a license on a subject invention should also confirm their invention-utilization reporting to the funding agency (commonly tracked through iEdison) reflects the change, since agencies use that reporting to monitor whether Bayh-Dole’s practical-application goal is being met.
Negotiating Termination Consequences: A Practical Checklist
- Does the reversion of rights and exclusivity happen automatically on the termination date, or does it require a further step by either party?
- Which of the three sublicense-disposition models applies — automatic termination, direct-license step-in rights, or assignment — and under what conditions can a sublicensee invoke it?
- What is the confidentiality survival term, and is there a residual-knowledge carve-out, and if so, how narrowly is it drafted?
- Is there a defined sell-off period for existing inventory, and does it require continued royalty payment?
- Who bears patent prosecution and maintenance costs during any transition period, and by when must the institution decide whether to continue prosecution itself?
- Do accrued-but-unpaid royalties, minimum annual royalties, and patent cost reimbursements survive termination as payment obligations?
- Does the audit-rights clause survive long enough to cover the final royalty-reporting period?
- What happens to grant-back rights in improvements the licensee had already disclosed versus improvements it develops after termination?
- For federally funded inventions, has invention-utilization reporting to the funding agency been updated to reflect the change in licensing status?
Frequently Asked Questions
Does patent ownership transfer back to the university when a license terminates?
Usually there is nothing to transfer, because the university held title throughout — the license granted a right to practice the patent, not ownership of it. What reverts is the licensee’s right to practice and, for an exclusive license, the exclusivity itself. The exception is where a licensee’s name appears on a filing as assignee or co-owner under a delegated-prosecution or joint-improvement arrangement; that does require an affirmative reassignment or further documentation to clear title.
Do sublicenses automatically end when the head license terminates?
It depends entirely on how the head license is drafted. Absent specific language, the default legal position is that a sublicense cannot survive the termination of the rights it was carved out of. Many university licenses instead include a direct-license or step-in right letting a performing, non-breaching sublicensee request a direct license from the institution on comparable terms — but that protection has to be written into the agreement; it is not automatic.
Is “use-it-or-lose-it” the same thing as a diligence clause?
“Use-it-or-lose-it” is informal shorthand for the outcome a diligence-and-termination-for-failure-to-commercialize clause produces, not a separate legal mechanism. See CASRAI’s diligence milestones guide for how the underlying trigger is actually structured and negotiated.
What happens to confidential information the licensee received during the relationship?
Confidentiality obligations typically survive termination for a defined term (or, for genuine trade secrets, potentially indefinitely), and the licensee is commonly required to return or destroy the institution’s confidential materials, sometimes with a written certification. Narrowly drafted residual-knowledge language sometimes lets personnel retain general skills and know-how carried in unaided memory, distinct from the confidential information itself.
Can a licensee keep selling existing inventory after termination?
Only if the license includes a sell-off or wind-down provision, which many do — typically a short, fixed window to sell through finished goods already manufactured, with royalties still due on those sales. Without that clause, the default expectation is that authorized sales stop on the termination date.
Related reading: CASRAI’s technology transfer pillar page; the exclusive vs. non-exclusive license comparison; and the guide to license agreement structure for how these clauses fit into a full agreement.
